RT Journal Article
SR Electronic
T1 Adrenaline rush in athletes: Visualizing glucose fluctuations during high-intensity races
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.05.12.23289815
DO 10.1101/2023.05.12.23289815
A1 Kajisa, Taira
A1 Sakai, Toshiyuki
YR 2023
UL http://medrxiv.org/content/early/2023/05/16/2023.05.12.23289815.abstract
AB Under stressful or exciting conditions, athletes can perform beyond their typical capabilities during a so-called “adrenaline rush.” In the preliminary study by one sub-elite runner, we found that even in the fasted state, hyperglycemia occurs during high loaded running by the fact that both blood glucose and interstitial fluid glucose levels rose rapidly to 11-12 mM. This suggests that glycogen in the liver is degraded by anti-stress hormones, leading to an increase in glucose concentration. In the next, we analyzed the temporal changes in interstitial glucose concentration before, during, and after races using continuous glucose monitoring (CGM) data obtained from a total of 36 elite long-distance athletes including walking race (non-fasting state). We found that even healthy subjects recorded high glucose levels (mean 8.3 ± 1.5 mM) before the start of the race and the glucose fluctuations during the race were also recorded at 11.2 ± 2.2 mM, suggesting not only blood glucose level fluctuation due to supplementation before the races, but also due to the effects of stress hormones such as epinephrine, cortisol and glucagon. Furthermore, the mean glucose level during the daytime for the three days before the race event was significantly different by 0.3 mM (p<0.001) compared to the mean during the daytime for the three days after the race. These results suggested that efficient utilization of liver glycogen is important to keep high performance throughout the race, since the liver glycogen also consumed under stress.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe authors received no specific funding for this work.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:All procedures were approved by the ethical review committee for medical research involving human subjects at Toyo University (TU2021-006).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll relevant data are within the manuscript and its Supporting Information files. All data produced are available online at 10.6084/m9.figshare.22807130. https://doi.org/10.6084/m9.figshare.22807130.